Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion
Author:
Funder
Canadian Institutes of Health Research
Ontario Veterinary College, University of Guelph
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference76 articles.
1. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer;T Browder;Cancer Res,2000
2. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity;G Klement;J Clin Invest,2000
3. Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice;D Hanahan;J Clin Invest,2000
4. Metronomic chemotherapy: new rationale for new directions;E Pasquier;Nat Rev Clin Oncol,2010
5. Cyclophosphamide-methotrexate 'metronomic' chemotherapy for the palliative treatment of metastatic breast cancer. A comparative pharmacoeconomic evaluation;G Bocci;Ann Oncol,2005
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy of Cold Atmospheric Plasma vs. Chemotherapy in Triple-Negative Breast Cancer: A Systematic Review;International Journal of Molecular Sciences;2024-03-13
2. Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation;Frontiers in Oncology;2022-11-30
3. Daphnoretin Arrests the Cell Cycle and Induces Apoptosis in Human Breast Cancer Cells;Journal of Natural Products;2022-09-26
4. Metronomic chemotherapy and antiangiogenic drugs: Preclinical and clinical data;Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy;2022
5. Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer;npj Breast Cancer;2020-07-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3